Ao Wang
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.
Journal: Toxicology letters
Published: September 18, 2021
O-alkyl and o-benzyl hesperetin derivative-1L attenuates inflammation and protects against alcoholic liver injury via inhibition of BRD2-NF-κB signaling pathway.
Journal: Toxicology
Published: August 03, 2021
Hesperetin derivative decreases CCl4 -induced hepatic fibrosis by Ptch1-dependent mechanisms.
Journal: Journal of biochemical and molecular toxicology
Published: July 18, 2021
LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5.
Journal: European journal of pharmacology
Published: July 14, 2021
Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway.
Journal: European journal of pharmacology
Published: March 24, 2021
Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.
Journal: Current pharmaceutical design
Published: May 06, 2020
Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis.
Journal: Molecular therapy. Nucleic acids
Published: March 15, 2020
LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 27, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026